v2.4.0.6
Consolidated Statement of Cash Flows (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 29, 2012
Dec. 31, 2011
Dec. 25, 2010
Operating Activities      
Net income $ 6,214 $ 6,462 $ 6,338
Depreciation and amortization 2,689 2,737 2,327
Stock-based compensation expense 278 326 299
Merger and integration costs 16 329 808
Cash payments for merger and integration costs (83) (377) (385)
Restructuring and impairment charges 279 383   
Cash payments for restructuring charges (343) (31) (31)
Restructuring and other charges related to the transaction with Tingyi 176      
Cash payments for restructuring and other charges related to the transaction with Tingyi (109)      
Gain on previously held equity interests in PBG and PAS       (958)
Asset write-off       145
Non-cash foreign exchange loss related to Venezuela devaluation       120
Excess tax benefits from share-based payment arrangements (124) (70) (107)
Pension and retiree medical plan contributions (1,865) (349) (1,734)
Pension and retiree medical plan expenses 796 571 453
Bottling equity income, net of dividends       42
Deferred income taxes and other tax charges and credits 321 495 500
Change in accounts and notes receivable (250) (666) (268)
Change in inventories 144 (331) 276
Change in prepaid expenses and other current assets 89 (27) 144
Change in accounts payable and other current liabilities 548 520 488
Change in income taxes payable (97) (340) 123
Other, net (200) (688) (132)
Net Cash Provided by Operating Activities 8,479 8,944 8,448
Investing Activities      
Capital spending (2,714) (3,339) (3,253)
Sales of property, plant and equipment 95 84 81
Acquisition of manufacturing and distribution rights from DPSG       (900)
Investment in WBD    (164) (463)
Cash payments related to the transaction with Tingyi (306)      
Other acquisitions and investments in noncontrolled affiliates (121) (601) (83)
Divestitures (32) 780 12
Short-term investments, by original maturity      
More than three months – purchases       (12)
More than three months – maturities    21 29
Other investing, net 12 (16) (17)
Net Cash Used for Investing Activities (3,005) (5,618) (7,668)
Financing Activities      
Proceeds from issuances of long-term debt 5,999 3,000 6,451
Payments of long-term debt (2,449) (1,596) (59)
Debt repurchase    (771) (500)
Short-term borrowings, by original maturity      
More than three months – proceeds 549 523 227
More than three months – payments (248) (559) (96)
Three months or less, net (1,762) 339 2,351
Cash dividends paid (3,305) (3,157) (2,978)
Share repurchases – common (3,219) (2,489) (4,978)
Share repurchases – preferred (7) (7) (5)
Proceeds from exercises of stock options 1,122 945 1,038
Excess tax benefits from share-based payment arrangements 124 70 107
Acquisition of noncontrolling interests (68) (1,406) (159)
Other financing (42) (27) (13)
Net Cash (Used for)/Provided by Financing Activities (3,306) (5,135) 1,386
Effect of exchange rate changes on cash and cash equivalents 62 (67) (166)
Net Increase/(Decrease) in Cash and Cash Equivalents 2,230 (1,876) 2,000
Cash and Cash Equivalents, Beginning of Year 4,067 5,943 3,943
Cash and Cash Equivalents, End of Year 6,297 4,067 5,943
Non-cash activity:      
Issuance of common stock and equity awards in connection with our acquisitions of PBG and PAS, as reflected in investing and financing activities       4,451
PBG and PAS Acquisition [Member]
      
Investing Activities      
Acquisition, net of cash and cash equivalents acquired       (2,833)
WBD [Member]
      
Investing Activities      
Acquisition, net of cash and cash equivalents acquired    (2,428)   
Three Months Or Less Maturity [Member]
      
Short-term investments, by original maturity      
Three months or less, net $ 61 $ 45 $ (229)